All Stories

  1. Hypervirulent Klebsiella pneumoniae: a new public health threat

    Article • Expert Review of Anti-infective Therapy, November 2018, Taylor & Francis

    Thomas Russo

  2. Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae

    Article • Journal of Clinical Microbiology, June 2018, ASM Journals

    Chi-Tai Fang, Thomas Russo

  3. The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies

    Article • Infection and Immunity, September 2017, ASM Journals

    Thomas Russo

  4. Metabolite Transporter PEG344 Is Required for Full Virulence of Hypervirulent Klebsiella pneumoniae Strain hvKP1 after Pulmonary but Not Subcutaneous Challenge

    Article • Infection and Immunity, July 2017, ASM Journals

    Thomas Russo

  5. The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii

    Article • mSphere, May 2016, ASM Journals

    Thomas Russo, Dr Timothy C Umland

  6. Aerobactin, but Not Yersiniabactin, Salmochelin, or Enterobactin, Enables the Growth/Survival of Hypervirulent (Hypermucoviscous) Klebsiella pneumoniaeEx VivoandIn Vivo

    Article • Infection and Immunity, June 2015, ASM Journals

    Thomas Russo

  7. Aerobactin Mediates Virulence and Accounts for Increased Siderophore Production under Iron-Limiting Conditions by Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae

    Article • Infection and Immunity, March 2014, ASM Journals

    Thomas Russo

  8. Draft Genome Sequence of the Hypervirulent Klebsiella pneumoniae Strain hvKP1, Isolated in Buffalo, New York

    Article • Genome Announcements, March 2013, ASM Journals

    Thomas Russo

  9. The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization

    Article • Infection and Immunity, January 2013, ASM Journals

    Thomas Russo